Floatz logo

Dehydrated Human Amnion/Chorion Membrane (Dhacm)

Plantar Fasciitis

Explore 1 assets in Plantar Fasciitis
Floatz Rating
BBB72/100
Confidence
Indicative
v0.2
Sponsor
MiMedx Group, Inc.
Modality
other_biological
Development Phase
Phase 3
Status
Dormant
Evidence ledger · v0.2

Clinical Evidence

Clinical track record: trial progression, reported outcomes, safety signals, and endpoint quality.
60Moderate confidence
Detailed axis rationale is planned and will be published soon.

No trial-level evidence is linked to this axis yet.

Competitive Position

Competitive setting: how crowded the indication is, class-level failures, and timing against rivals.
95High confidence
Detailed axis rationale is planned and will be published soon.

Same indication · Plantar Fasciitis

AssetSponsorPhaseRating
Dehydrated Human Amnion/Chorion Membrane (Dhacm) (this asset)MiMedx Group, Inc.P3BBB · 72
AcetylcysteineUniversity of ArizonaP2CCC
AbobotulinumtoxinaUniversity Foot and Ankle FoundationP2CC

Other indications for Dehydrated Human Amnion/Chorion Membrane (Dhacm)

IndicationSponsorPhaseRating
Prostate CancerP2CC · 46
Kidney NeoplasmN/AD · 30
Kidney CancerN/AD · 30

Scientific Foundation

Strength of the underlying biology: target validation, tractability, modality fit, and how related mechanisms have fared.
NR

Planned for methodology v0.2.

Development Feasibility

How realistically the program can be executed, drawing on modality precedent, enrollment dynamics, and sponsor delivery.
NR

Planned for methodology v0.2.

Commercial Opportunity

Commercial prize: addressable population, unmet need, and the value case for the indication.
NR

Planned for methodology v0.2.

IP & Exclusivity

Exclusivity position, covering patent protection and freedom-to-operate runway.
NR

Planned for methodology v0.2.

Manufacturing & Supply

Manufacturing and supply readiness, driven by modality process and scale-up risk.
NR

Planned for methodology v0.2.

Related assets

Citation

Floatz Terminal. Dehydrated Human Amnion/Chorion Membrane (Dhacm) in Plantar Fasciitis. Methodology v0.2.
Rated under v0.2 effective July 8, 2026. Last refreshed July 8, 2026.
Accessed July 14, 2026.
https://terminal.floatz.ai/assets/dehydrated-human-amnionchorion-membrane-dhacm-plantar-fasciitis

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →